Financhill
Back

Supernus Pharmaceuticals Vs. Mercury Systems Industry Stock Comparison

Buy
51

SUPN
Supernus Pharmaceuticals

Last Price:
37.24
Seasonality Move:
8.24%
Sell
48

MRCY
Mercury Systems

Last Price:
41.37
Seasonality Move:
7.56%
Buy
51
Supernus Pharmaceuticals (SUPN) is a Buy

Is Supernus Pharmaceuticals a Buy, Sell or Hold?

  • The current Supernus Pharmaceuticals [SUPN] share price is $37.75. The Score for SUPN is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
  • SUPN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
48
Mercury Systems (MRCY) is a Sell

Is Mercury Systems a Buy, Sell or Hold?

  • The current Mercury Systems [MRCY] share price is $42.23. The Score for MRCY is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • MRCY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SUPN Stock Price Chart

What is Supernus Pharmaceuticals's stock price today?

  • The Supernus Pharmaceuticals share price today is $37.75
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SUPN is experiencing buying pressure, which is a positive indicator for future bullish movement.

MRCY Stock Price Chart

What is Mercury Systems's stock price today?

  • The Mercury Systems share price today is $42.23
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MRCY is experiencing buying pressure, which is a positive indicator for future bullish movement.

SUPN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.83 Buy
Relative Strength Index (14 RSI): 76.85 Buy
Chaikin Money Flow: 420499 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (32.37 - 34.89) Buy
Bollinger Bands (100): (28.44 - 34.28) Buy

MRCY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.08 Sell
Relative Strength Index (14 RSI): 76.86 Buy
Chaikin Money Flow: 877819 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (33.13 - 37.29) Buy
Bollinger Bands (100): (31.06 - 37.88) Buy

SUPN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 34.84 Buy
20-day SMA: 34 Buy
50-day SMA: 33.09 Buy
200-day SMA: 30.61 Buy
8-day EMA: 35.11 Buy
20-day EMA: 34.16 Buy
50-day EMA: 33.11 Buy
200-day EMA: 31.13 Buy

MRCY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 34.48 Buy
20-day SMA: 34.74 Buy
50-day SMA: 36.05 Buy
200-day SMA: 31.96 Buy
8-day EMA: 35.51 Buy
20-day EMA: 35.08 Buy
50-day EMA: 35.33 Buy
200-day EMA: 34.17 Buy

Supernus Pharmaceuticals Earnings Growth & SUPN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.87 per share, and a decrease next year of $0.96 per share.

Mercury Systems Earnings Growth & MRCY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.38 per share, and an increase next year of $1.20 per share.

Supernus Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Mercury Systems Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):